Author's posts
Importance Of Formulating A U.S. Policy On Covid-19 Vaccine Passports To Facilitate Future International Travel
While it may be understandable for the White House to rule out federal preconditions of proof of Covid-19 vaccination for domestic purposes, it must formulate a coherent policy on international travel requirements, which may include proof of vaccinatio…
O Canada: Woefully Behind On Vaccinations, And Seeing A Surge In Cases Of Variants Of Concern
Canada’s rate of new coronavirus cases per million people is closing in on that of the U.S., and could overtake it if the trend continues. Public health officials and physicians are particularly concerned about the rapid spread of both the B.1.1.7 and …
Secretary Of HHS Becerra To Focus On Anti-Competitive Practices In Hospital, PBM, And Pharmaceutical Industries
It’s been suggested that the newly confirmed Secretary of HHS, Xavier Becerra, poses a greater threat than his predecessor, Alex Azar, to the pharmaceutical industry. Becerra is likely, however, to focus his attention more broadly on anti-competitive p…
In Some U.S. States Booking A Vaccine Appointment Is Still A Chaotic Free-For-All
If you’ve attempted to get a Covid-19 vaccine appointment in certain U.S. states, you probably know how frustrating the process is. A potentially life-saving vaccine shouldn’t be this hard to get.
Inclusion Of H.R. 3 Drug Price Control Measures In Infrastructure Bill May Negatively Impact Drug Industry
Aspects of H.R. 3 may be included in a pending infrastructure package. Should the infrastructure bill be enacted, with H.R. 3 price control measures that include international price indexing, it may have negative ramifications for the biopharmaceutical…
Profiting From Success: The Future Of Covid-19 Vaccine Pricing
The future price of Covid-19 vaccines will depend on numerous market factors, including comparative clinical value, competition among manufacturers, and projected numbers of people who require booster shots. But, the federal government will also have a…
Biden Administration Weighs Temporarily Suspending IP Protections For Covid-19 Vaccine Developers
The Biden Administration is considering whether to temporarily lift intellectual property protections on Covid-19 treatments and vaccines. The Administration will need to tread a very fine line if it decides to try and coax companies into selling their…
Bungled E.U. Covid-19 Vaccination Rollout Jeopardizes Return To Near-Normal Later This Year
The surge in coronavirus infections across a large part of Europe is relentless. Relaxing mitigation measures too soon has contributed to the current wave. But a poorly managed vaccination rollout throughout most of the EU has exacerbated the problem a…
Latest Covid-19 Variant Discovered In France Isn’t Detected By Standard PCR Tests
The biggest concern with variants that escape detection is that they may fuel spread of the disease. And this can spawn new, more potent variants. The driving force behind the emergence of variants of concern, such as the B.1.1.7, B.1.351, and P.1, is …
Metamorphosis Of A Dutch Top Public Health Official, Jaap Van Dissel, In The Face Of The Covid-19 Pandemic
Last year van Dissel downplayed the virus and promoted a herd immunity approach. Now he dons a mask in public, advises against loosening the lockdown reins until there is sustained improvement in Covid-19 indicators, and doesn’t talk about naturally ac…
